<DOC>
	<DOCNO>NCT01936012</DOCNO>
	<brief_summary>The present study conduct find whether bioavailability 10 mg lisinopril tablet produce PT Dexa Medica equivalent tablet produce innovator ( Zestril® 10 mg , PT Boehringer Ingelheim Indonesia , Indonesia , license Astra Zeneca UK Ltd . )</brief_summary>
	<brief_title>Bioequivalence Study Two Formulations 10 mg Lisinopril Tablet Under Fasting Condition</brief_title>
	<detailed_description>This randomize , single-blind , two-period , two-sequence , cross-over study fast condition . The participate subject require overnight fast next morning give orally one tablet test drug ( Lisinopril 10 mg , produce PT Dexa Medica ) one tablet reference drug ( Zestril® 10 mg , PT Boehringer Ingelheim Indonesia , Indonesia , license Astra Zeneca UK Ltd. ) . Blood sample draw immediately take drug ( control ) , 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 12 , 16 , 24 , 36 , 48 hour drug administration . Seven day first drug administration ( washout period ) , procedure repeat use alternate drug . The pharmacokinetic parameter , include AUCt , AUCinf , Cmax , max , t1/2 , determine plasma concentration lisinopril , use liquid chromatography tandem mass spectrometry detection ( LC-MS/MS ) method .</detailed_description>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>Healthy male female subject . Aged 18 55 year inclusive . Nonsmokers moderate smoker ( less 10 cigarette per day ) . Able participate , communicate well investigator willing provide write informed consent participate study . Body mass index within 18 25 kg/m2 . Vital sign ( 10 minute rest ) within follow range : systolic blood pressure 110 120 mmHg diastolic blood pressure 70 80 mmHg pulse rate 60 90 bpm Personal/family history allergy hypersensitivity contraindication lisinopril ally drug . Pregnant lactate woman . Any major illness clinically significant ongoing chronic medical illness past 90 day . Any clinically significant abnormality liver function test ( ALT , AP , total bilirubin &gt; = 1.5 ULN ) . Any clinically significant abnormality renal function test ( serum creatinine concentration &gt; 1.4 mg/dL ) . Positive hepatitis B surface antigen ( HBsAg ) , antiHCV , antiHIV . Clinically significant hematology abnormality . Clinically significant electrocardiogram ( ECG ) abnormality . Any surgical medical condition might significantly alter absorption , distribution , metabolism , excretion study drug . Past history anaphylaxis angioedema . History drug alcohol abuse within 12 month prior screen . Participation clinical trial within past 90 day . History bleed coagulative disorder . History difficulty donate blood accessibility vein leave right arm . A donation loss 500 mL ( ) blood within 3 month study 's first dosing day . Intake prescription nonprescription drug , food supplement , herbal medicine within 14 day study 's first dosing day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Lisinopril</keyword>
	<keyword>Bioequivalence</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Angiotensin-converting enzyme inhibitor</keyword>
</DOC>